|
|
Article: Dermatologic Surgery Journal Publishes Landmark Study Showing Positive Five-Year Effects of ArteFill for Smile Lines.(Clinical report)
- Article from:
- Business Wire
- Article date:
- December 10, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN DIEGO -- Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill[R] is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial fold or "smile line" wrinkles, today announced the publication of positive data from a long-term safety and efficacy study of ArteFill in the December Filler Issue of Dermatologic Surgery, a peer-reviewed publication of the American Society for Dermatologic Surgery. The study is available at http://delivery.sheridan.com/index.php?ID=blk/BLK_130959_CP.
Results from the study, led by Steven R. Cohen, MD, Clinical Professor, Division of Plastic Surgery, ...